Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Vehicle Controlled, Efficacy and Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Conditions
Interventions
Olumacostat Glasaretil Gel, 5.0%
Olumacostat Glasaretil Gel, Vehicle
Locations
49
United States
Alliance Dermatology & MOHS Center
Phoenix, Arizona, United States
Anaheim Clinical Trials
Anaheim, California, United States
Dermatology Research Associates
Los Angeles, California, United States
Rady Children's Hospital UCSD Pediatric and Adolescent Derm
San Diego, California, United States
University Clinical Trials Inc.
San Diego, California, United States
Horizons Clinical Research Center, LLC
Denver, Colorado, United States
Start Date
December 27, 2016
Primary Completion Date
November 28, 2017
Completion Date
November 28, 2017
Last Updated
July 20, 2021
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Dermira, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions